A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
Clinical trial NCT06804603 · COMPLETED
Trial details
- NCT number
- NCT06804603
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-25
- Primary completion
- 2025-10-06
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.